Changes to Size of Drug Discount Program Would Not Affect Overall Spending

Modifications to the 340B program would alter discounts only for manufacturers, hospitals

Navigate to:

Changes to Size of Drug Discount Program Would Not Affect Overall Spending

Legislators considering changes to the 340B Drug Pricing Program have inquired about its size and scope. In a new Health Affairs blog post, experts from The Pew Charitable Trusts estimate the size of the program, as well as the impact that discounts have on prescription drug sales and manufacturer revenue. Their analysis finds that changes to the size of the 340B program would not affect overall drug spending and would alter only the distribution of discounts between manufacturers and hospitals.

Read the blog post.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.